ClinicalTrials.gg
Not yet recruitingNCT06719323Updated Jan 12, 2026

Long-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease

An interventional study of Family Walking Instruction with Support by Heart (Family WISH) program and Comparison group in Heart Defects, Congenital, sponsored by Chi-Wen Chen. Not yet recruiting at 1 site in Taiwan. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by Chi-Wen Chen · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Heart Defects, Congenital with a site in Taiwan — 3 open to participants now, 5 under way, none of them phase 3. Heart Defects, Congenital · Taiwan.

Planned enrollment
7th of 10
104 · median 120
Started
2026
with 1 other
No phase
7 of 13
3 open now
Registered
10th of 13
by date
Lead sponsor
1 of 13
Chi-Wen Chen

Among the 13 studies in Heart Defects, Congenital with a site in Taiwan, this one is the 7th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 10th registered.

Heart Defects, Congenital

992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.

Browse Heart Defects, Congenital studies →

Open to participants now

3 of the 13 studies in Heart Defects, Congenital with a site in Taiwan are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Heart Defects, Congenital with a site in Taiwan, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn the long-term effects of "Family Walking Instruction with Support by Heart" (Family WISH) on frailty state, quality of life and family functioning among adolescents with congenital heart disease (CHD).

Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.

Participants will:

  • Walk with family members for 20-30 minutes daily, at least 5 times per week, totaling 150 minutes per week.
  • Keep a diary to record the frequency of their walks and any symptoms experienced.
  • Complete questionnaires at baseline, and at 6, 12, and 24 weeks.
03

Conditions studied

  • Heart Defects, Congenital
04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being between 12 and 18 years old;
  • having received a diagnosis of CHD by a physician before age 2;
  • having received a diagnosis of CHD with (NYHA) functional class I, II, or III;
  • having parents or guardians who were able to communicate in Mandarin, and being able to communicate in Mandarin themselves;
  • not having cognitive impairments, and;
  • voluntarily signing forms.

Exclusion criteria

Exclusion Criteria:

  • undergoing heart transplant surgery within the past year;
  • receiving cardiac catheterization intervention or open-heart surgery within the past 6 months;
  • having CHD with functional class IV; and
  • having other congenital diseases
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
104 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Experimental group: a 12-week Family WISH program

  • Sham comparator
    Comparison group

    Comparison group: a family walking health education sheet received

    Behavioral: Comparison group

Interventions

  • BehavioralFamily Walking Instruction with Support by Heart (Family WISH) program

    Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.

  • BehavioralComparison group

    a family walking health education sheet received

06

What researchers measure

Primary outcomes

  1. frailty state

    self-reported questionnaire completed

    Time frame: at baseline, and at 6, 12, and 24 weeks

Secondary outcomes

  1. quality of life and family functioning

    self-reported questionnaires completed

    Time frame: at baseline, and at 6, 12, and 24 weeks

07

Study locations

1 site
  • College of Nursing, National Yang Ming Chiao Tung University
    Taipei, 112304, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jul 2027, 13 months later.

Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 13 months is below that.

Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2024
First posted
Dec 5, 2024
StartEst.
Jun 1, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06719323
Lead sponsor
Chi-Wen Chen
Responsible party
Chi-Wen Chen (Professor, National Yang Ming Chiao Tung University) — Sponsor-investigator
First posted
Dec 5, 2024
Start date
Jun 1, 2026 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jan 12, 2026

Study contacts

Chi-Wen Chen, PhD
Contact
chiwenchen@nycu.edu.tw
011-886-228267348

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion